N06AB02 Zimelidine N06AB03 Fluoxetine N06AB04 Citalopram

N06AB05 Paroxetine N06AB06 Sertraline N06AB07 Alaproclate

N06AB08 Fluvoxamine N06AB09 Etoperidone N06AB10 Escitalopram

PRODUCTS - WORLD HEALTH ORGANIZATION

NERVOUS SYTEM (N)

Anatomical Therapeutic Chemical Classification System

SSRP 12.5 mg
SSRP 12.5 mg
SSRE 10/.25 mg
SSRE 10/.25 mg
SSRS 100 mg
SSRS 100 mg

N06AB05 Paroxetine

N06AB10 Escitalopram

N06AB06 Sertraline

N03AE01 Clonazepam

WHO GMP Classification
WHO GMP Classification

Selective Serotonin Reuptake Inhibitor. World Health Organization's (WHO) list of Essential Medicine. Powerful and selective inhibition of 5-HT reuptake.

Paroxetin 12.5 mg

SSRE

A unique combination of the purest SSRI to increase available Seratonin and GABA positive allosteric modulator. Also popularly categorized as ASRI (Allosteric Serotonin Reuptake Inhibitor).Treatment of Major Depressive Disorder (in ages 12 and older) and Generalized Anxiety Disorder (MOD and GAD)

PRODUCTS

SSRP

SSRP 12.5
SSRP 12.5

Escitalopram + Clonazepam 10/0.25 mg

SSRE 10/.25
SSRE 10/.25

SSRS

Selective Serotonin Reuptake Inhibitor. World Health Organization's (WHO) list of Essential Medicine. Central Nervous System stimulation rather than sedation.

Sertraline 100 mg

SSRS 100
SSRS 100

CYP2D6 Substrate Inhibitor and strong CYP2D6 inhibitor

Our Work
WHO GMP manufactured
WHO GMP manufactured

Projects and Innovations

We have successfully completed numerous formulations focused on cognitive enhancement and skin care. Our innovative formulations have shown great efficacy with minimal side effects.

R&D at Aston Sequoia
R&D at Aston Sequoia
Research and Development

Our dedicated team of researchers and scientists are constantly working on new projects to improve cognitive health. Stay tuned for our upcoming innovations.

Worldwide collaborations and trials
Worldwide collaborations and trials
Clinical Trials

We conduct rigorous clinical trials to ensure the safety and efficacy of our products. Our commitment to quality is reflected in the results of these trials.